Associated Papers
Meta-Analysis of Gene Expression in Bulk-Processed Post-Mortem Spinal Cord from ALS Patients and Normal Controls.
Swindell WR
Neurosci, 2025
Exploring YAP1-centered networks linking dysfunctional CFTR to epithelial-mesenchymal transition.
Quaresma MC et al.
Life Science Alliance, 2022
RhoA-ROCK competes with YAP to regulate amoeboid breast cancer cell migration in response to lymphatic-like flow.
Mohammadalipour A et al.
Faseb Bioadvances, 2022
Selection of established tumour cells through narrow diameter micropores enriches for elevated Ras/Raf/MEK/ERK MAPK signalling and enhanced tumour growth.
Rudzka DA et al.
Small Gtpases, 2021
Multi-omic analysis elucidates the genetic basis of hydrocephalus.
Hale AT et al.
Cell Reports, 2021
A cyclin D-CDK6 dimer helps to reshuffle cyclin-dependent kinase inhibitors (CKI) to overcome TGF-beta-mediated arrest and maintain CDK2 activity.
Nataraj SE et al.
Cell Cycle (georgetown, Tex.), 2021
The double dealing of cyclin D1.
Tchakarska G et al.
Cell Cycle (georgetown, Tex.), 2020
Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3-NANOG Axis.
Oh SJ et al.
Cancer Research, 2018
Pan-cancer screen for mutations in non-coding elements with conservation and cancer specificity reveals correlations with expression and survival.
Hornshøj H et al.
Npj Genomic Medicine, 2018
CDK4 protein is degraded by anaphase-promoting complex/cyclosome in mitosis and reaccumulates in early G1 phase to initiate a new cell cycle in HeLa cells.
Chen H et al.
The Journal of Biological Chemistry, 2017
EZH2 alterations in follicular lymphoma: biological and clinical correlations.
Huet S et al.
Blood Cancer Journal, 2017
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome.
Marziali G et al.
Scientific Reports, 2016
Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.
Awad KS et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology, 2016
Consequence of the tumor-associated conversion to cyclin D1b.
Augello MA et al.
Embo Molecular Medicine, 2015
Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression.
Lee Y et al.
Nature, 2014
Cyclin-dependent kinase 4 may be expressed as multiple proteins and have functions that are independent of binding to CCND and RB and occur at the S and G 2/M phases of the cell cycle.
Sun Y et al.
Cell Cycle (georgetown, Tex.), 2013
Basic anatomy and tumor biology of the RPS6KA6 gene that encodes the p90 ribosomal S6 kinase-4.
Sun Y et al.
Oncogene, 2013
A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.
Jirawatnotai S et al.
Nature, 2011
Complex alternative splicing of the smarca2 gene suggests the importance of smarca2-B variants.
Yang M et al.
Journal of Cancer, 2011
Cyclins, Cdks, E2f, Skp2, and more at the first international RB Tumor Suppressor Meeting.
Bremner R et al.
Cancer Research, 2010
Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists.
Wang Y et al.
Cancer Research, 2008
The LxCxE pRb interaction domain of cyclin D1 is dispensable for murine development.
Landis MW et al.
Cancer Research, 2007
Requirement for CDK4 kinase function in breast cancer.
Yu Q et al.
Cancer Cell, 2006
Negative regulation of TSC1-TSC2 by mammalian D-type cyclins.
Zacharek SJ et al.
Cancer Research, 2005
Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage.
Agami R et al.
Cell, 2000